Research map: Köhlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathy

Back to the article

Papers in this map

  1. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus · M.C. Hochberg · 1997 · 11598 citations · Cited by this paper
  2. Leave No Data Behind: Exploring a new paradigm in oncology with foundation models and large language models · 2026 · Related
  3. The single-cell transcriptional landscape of mammalian organogenesis · Junyue Cao · 2019 · 4985 citations · Cited by this paper
  4. Self-sufficient killing of malignant tumors by an engineered cancer-selective gene circuit · 2026 · Related
  5. The molecular machinery of regulated cell death · Daolin Tang · 2019 · 2608 citations · Cited by this paper
  6. Persistent cytolytic CD8+ T cells recognize SARS-CoV-2 and herpesvirus epitopes in long COVID · 2026 · Related
  7. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome · Caroline H. Shiboski · 2016 · 1425 citations · Cited by this paper
  8. Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitination · 2026 · Related
  9. IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy · Jun‐Li Luo · 2005 · 882 citations · Cited by this paper
  10. Combine antibody-drug conjugate with cmLumiOpto for triple-negative breast cancer treatment · 2026 · Related
  11. TGF-β1 Signaling and Tissue Fibrosis · Kevin K. Kim · 2017 · 818 citations · Cited by this paper
  12. Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4+CD8+ T cells · 2026 · Related
  13. Intracellular Iron Transport and Storage: From Molecular Mechanisms to Health Implications · Elizabeth L. Mackenzie · 2008 · 542 citations · Cited by this paper
  14. Therapeutic Gfral silencing via antisense oligonucleotides ameliorates cancer-associated cachexia and extends survival in tumor-bearing mice · 2026 · Related
  15. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients · Pierre Bost · 2020 · 529 citations · Cited by this paper
  16. Metabolomic and lifestyle profiles refine BMI-metabolic phenotypes in older adults · 2026 · Related
  17. scRepertoire: An R-based toolkit for single-cell immune receptor analysis · Nicholas C. Borcherding · 2020 · 515 citations · Cited by this paper
  18. Alterations of the host-lung microbiome metasystem in systemic inflammatory response syndrome is associated with secondary pneumonia · 2026 · Related
  19. RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase · Justin V. McCarthy · 1998 · 444 citations · Cited by this paper
  20. An autonomous multimodal AI agent for evidence-grounded ophthalmic diagnosis · 2026 · Related
  21. IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival · Mei X. Wu · 1998 · 418 citations · Cited by this paper
  22. THE MANY ROLES OF c-Myc IN APOPTOSIS · E. Brad Thompson · 1998 · 337 citations · Cited by this paper
  23. Gene modulation and immunoregulatory roles of Interferonγ · Banishree Saha · 2009 · 300 citations · Cited by this paper
  24. An IFN-Associated Cytotoxic Cellular Immune Response against Viral, Self-, or Tumor Antigens Is a Common Pathogenetic Feature in “Interface Dermatitis” · Joerg Wenzel · 2008 · 211 citations · Cited by this paper
  25. Lichenoid Tissue Reaction/Interface Dermatitis: Clinical and Histological Perspectives · Richard Dennis Sontheimer · 2009 · 131 citations · Cited by this paper
  26. Multiple Hautnekrosen bei Thrombangiitis obliterans · Walter Köhlmeier · 1941 · 124 citations · Cited by this paper
  27. Degos Disease · CYNTHIA M.J. MAGRO · 2011 · 117 citations · Cited by this paper
  28. Malignant atrophic papulosis (Köhlmeier-Degos disease) - A review · Athanasios Theodoridis · 2013 · 107 citations · Cited by this paper
  29. Malignant and benign forms of atrophic papulosis (Köhlmeier-Degos disease): systemic involvement determines the prognosis · Athanasios Theodoridis · 2013 · 88 citations · Cited by this paper
  30. Cell death–mediated cytokine release and its therapeutic implications · David E. Place · 2019 · 87 citations · Cited by this paper
  31. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study · Alessandro Maria Vannucchi · 2020 · 77 citations · Cited by this paper
  32. The effects of Eculizumab on the pathology of malignant atrophic papulosis · CYNTHIA M.J. MAGRO · 2013 · 72 citations · Cited by this paper
  33. The role of thrombospondin-1 in cardiovascular health and pathology · Smriti Murali Krishna · 2013 · 65 citations · Cited by this paper
  34. Benign Cutaneous Degos' Disease · Jeff D. Harvell · 2001 · 54 citations · Cited by this paper
  35. Relationship between CD4+/CD8+ T Cell Ratio and T Cell Activation in Systemic Lupus Erythematosus · Ichiro Maeda · 1999 · 54 citations · Cited by this paper
  36. Dynamic control of gene expression by ISGF3 and IRF1 during IFNβ and IFNγ signaling · Aarathy Ravi Sundar Jose Geetha · 2024 · 22 citations · Cited by this paper
  37. Vascular and Macrophage Heme Oxygenase-1 in Hypertension: A Mini-Review · Marta Martínez‐Casales · 2021 · 21 citations · Cited by this paper
  38. Clinical and laboratory prognosticators of atrophic papulosis (Degos disease): a systematic review · Justin D. Lu · 2021 · 19 citations · Cited by this paper
  39. INEFFICACY OF INTRAVENOUS IMMUNOGLOBULINS AND INFLIXIMAB IN DEGOS’ DISEASE · Sandra De Breucker · 2008 · 17 citations · Cited by this paper

Source: OpenAlex (CC0)